The efficacy of lozenges containing L. brevis CD2 was also tested in the treatment of oral ulcers in Behcet’s syndrome patients, and a significant decrease in the number of oral ulcers after 1 and 2 weeks of therapy was observed [24]. Here, CD2 is linked to Oral ulcer.